Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
Protein

Major pollen allergen Ole e 1

Gene
N/A
Organism
Olea europaea (Common olive)
Status
Reviewed-Annotation score: Annotation score: 5 out of 5-Experimental evidence at protein leveli

Functioni

May be involved in recognition between pollen-stigma and pollen tube-style cells.

Names & Taxonomyi

Protein namesi
Recommended name:
Major pollen allergen Ole e 1
Alternative name(s):
Allergen Ole e I
Allergen: Ole e 1
OrganismiOlea europaea (Common olive)
Taxonomic identifieri4146 [NCBI]
Taxonomic lineageiEukaryotaViridiplantaeStreptophytaEmbryophytaTracheophytaSpermatophytaMagnoliophytaeudicotyledonsGunneridaePentapetalaeasteridslamiidsLamialesOleaceaeOleeaeOlea

Subcellular locationi

GO - Cellular componenti

Complete GO annotation...

Keywords - Cellular componenti

Endoplasmic reticulum, Secreted

Pathology & Biotechi

Allergenic propertiesi

Causes an allergic reaction in human. Major allergen from olive pollen. Important in Mediterranean countries.1 Publication

Mutagenesis

Feature keyPosition(s)DescriptionActionsGraphical viewLength
Mutagenesisi8V → A: 90% loss of IgG binding. 1 Publication1
Mutagenesisi9S → A: Loss of IgG binding. 1 Publication1
Mutagenesisi10Q → A: Loss of IgG binding. 1 Publication1
Mutagenesisi11F → A: Loss of IgG binding. 1 Publication1
Mutagenesisi26F → A: 70% loss of IgG binding. 1 Publication1
Mutagenesisi29E → A: Loss of IgG binding. 1 Publication1
Mutagenesisi30L → A: 50% loss of IgG binding. 1 Publication1
Mutagenesisi32E → A: Loss of IgG binding. 1 Publication1
Mutagenesisi33F → A: Loss of IgG binding. 1 Publication1
Mutagenesisi34I → A: 50% loss of IgG binding. 1 Publication1
Mutagenesisi49G → A: 50% loss of IgG binding. 1 Publication1
Mutagenesisi50D → A: 60% loss of IgG binding. 1 Publication1
Mutagenesisi51V → A: 50% loss of IgG binding. 1 Publication1
Mutagenesisi55E → A: Loss of IgG binding. 1 Publication1
Mutagenesisi56V → A: Loss of IgG binding. 1 Publication1
Mutagenesisi57G → A: Loss of IgG binding. 1 Publication1
Mutagenesisi58Y → A: Loss of IgG binding. 1 Publication1
Mutagenesisi59T → A: Loss of IgG binding. 1 Publication1
Mutagenesisi60R → A: 60% loss of IgG binding. 1 Publication1
Mutagenesisi65Y → A: 70% loss of IgG binding. 1 Publication1
Mutagenesisi67M → A: 50% loss of IgG binding. 1 Publication1
Mutagenesisi70E → A: Loss of IgG binding. 1 Publication1
Mutagenesisi107L → A: Loss of IgG binding. 1 Publication1
Mutagenesisi108N → A: Loss of IgG binding. 1 Publication1
Mutagenesisi109T → A: Loss of IgG binding. 1 Publication1
Mutagenesisi110V → A: Loss of IgG binding. 1 Publication1
Mutagenesisi112G → A: Loss of IgG binding. 1 Publication1
Mutagenesisi119P → A: 70% loss of IgG binding. 1 Publication1
Mutagenesisi120L → A: Loss of IgG binding. 1 Publication1
Mutagenesisi123F → A: Loss of IgG binding. 1 Publication1
Mutagenesisi125K → A: 80% loss of IgG binding. 1 Publication1
Mutagenesisi133Q → A: 50% loss of IgG binding and 40% loss if IgE binding. 1 Publication1
Mutagenesisi134V → A: 30% loss of IgG binding and 50% loss if IgE binding. 1 Publication1
Mutagenesisi135Y → A: No loss of IgG binding and 40% loss if IgE binding. 1 Publication1
Mutagenesisi136 – 145Missing : Decreased IgE binding. 1 Publication10
Mutagenesisi136N → A: 40% loss of IgG binding and 60% loss if IgE binding. 1 Publication1
Mutagenesisi137K → A: 20% loss of IgG binding and 80% loss if IgE binding. 1 Publication1
Mutagenesisi138L → A: 70% loss of IgG binding and 90% loss if IgE binding. 1 Publication1
Mutagenesisi139G → A: 30% loss of IgG binding and 90% loss if IgE binding. 1 Publication1
Mutagenesisi140M → A: 50% loss of IgG binding and 50% loss if IgE binding. 1 Publication1
Mutagenesisi141 – 145Missing : Decreased IgE binding. 1 Publication5
Mutagenesisi141Y → A: 90% loss of IgG binding and 95% loss if IgE binding. 2 Publications1
Mutagenesisi142P → A: 20% loss of IgG binding and 95% loss if IgE binding. 1 Publication1

Keywords - Diseasei

Allergen

Protein family/group databases

Allergomei482. Ole e 1.
483. Ole e 1.0101.
487. Ole e 1.0105.
488. Ole e 1.0106.
489. Ole e 1.0107.

PTM / Processingi

Molecule processing

Feature keyPosition(s)DescriptionActionsGraphical viewLength
ChainiPRO_00002151131 – 145Major pollen allergen Ole e 1Add BLAST145

Amino acid modifications

Feature keyPosition(s)DescriptionActionsGraphical viewLength
Disulfide bondi19 ↔ 901 Publication
Disulfide bondi22 ↔ 1311 Publication
Disulfide bondi43 ↔ 781 Publication
Glycosylationi111N-linked (GlcNAc...) (complex); alternate1
Glycosylationi111N-linked (GlcNAc...) (high mannose); alternate1

Post-translational modificationi

N-glycosylated; contains high mannose (Man(7)-GlcNAc) and partially fucosylated complex glycans (GlcNAc-Man(3)-Xyl-GlcNAc). Complex glycans may contribute to the antigenicity. Exists both in a glycosylated and in a non-glycosylated form. Ole e 1 and Ole e 1.0103 are the only non-glycosylated isoallergens.
A second potential glycosylation site exists at position 50 in cv. Bella de Espana and cv. Hojiblanca.

Keywords - PTMi

Disulfide bond, Glycoprotein

PTM databases

UniCarbKBiP19963.

Expressioni

Tissue specificityi

Expressed in tapetum and pollen grains. Not detected in petals, roots or leaves.1 Publication

Developmental stagei

Expressed at late stages of pollen development. Up-regulated during pollen germination and pollen tube growth.2 Publications

Family & Domainsi

Domaini

Regions 91-102 and 109-130 are immunodominant T-cell epitopes. Mutations in the C-terminus (135-145) reduce allergenic activity but do not change the ability to stimulate allergen-specific T-cells.

Sequence similaritiesi

Belongs to the Ole e I family.Curated

Family and domain databases

InterProiIPR006040. Allegen_Ole_e_I_CS.
IPR006041. Pollen_Ole_e1_allergen.
[Graphical view]
PANTHERiPTHR31614:SF2. PTHR31614:SF2. 1 hit.
PROSITEiPS00925. OLEEI. 1 hit.
[Graphical view]

Sequencei

Sequence statusi: Complete.

P19963-1 [UniParc]FASTAAdd to basket

« Hide

        10         20         30         40         50
EDIPQPPVSQ FHIQGQVYCD TCRAGFITEL SEFIPGASLR LQCKDKENGD
60 70 80 90 100
VTFTEVGYTR AEGLYSMLVE RDHKNEFCEI TLISSGRKDC NEIPTEGWAK
110 120 130 140
PSLKFKLNTV NGTTRTVNPL GFFKKEALPK CAQVYNKLGM YPPNM
Length:145
Mass (Da):16,330
Last modified:October 1, 1993 - v2
Checksum:i3F11F04E01C12C84
GO

Sequence cautioni

The sequence CAA73036 differs from that shown. Reason: Erroneous initiation.Curated
The sequence CAA73037 differs from that shown. Reason: Erroneous initiation.Curated
The sequence CAA73038 differs from that shown. Reason: Erroneous initiation.Curated

Polymorphismi

Several isoforms of the allergen exist due to polymorphism.

Natural variant

Feature keyPosition(s)DescriptionActionsGraphical viewLength
Natural varianti3I → V in Ole e 1.0102, Ole e 1.0103 and Ole e 1.0105. 1
Natural varianti8V → I in Ole e I.4. 1
Natural varianti12H → Y in Ole e I.4. 1
Natural varianti13I → V in strain: cv. Zard; variant 2. In Ole e I.4. 1
Natural varianti14Q → I in strain: cv. Bella de Espana; variants 1 and 2, cv. Loaime, cv. Lucio, cv. Menara; variants 1 and 2, cv. Picholine marocaine and cv. Picual; variant 1. 1
Natural varianti15G → L in strain: cv. Picual; variant 1. 1
Natural varianti15G → Q in strain: cv. Arbequina; variants 1 and 2 and cv. Bella de Espana; variant 3. 1
Natural varianti15G → R in strain: cv. Bella de Espana; variants 1 and 2, cv. Menara; variants 1 and 2 and cv. Picholine marocaine. 1
Natural varianti15G → S in strain: cv. Picual; variant 3. 1
Natural varianti15G → W in strain: cv. Loaime and cv. Picual; variant 2. 1
Natural varianti16Q → A in strain: cv. Arbequina; variant 1. 1
Natural varianti16Q → D in strain: cv. Arbequina; variant 2, cv. Bella de Espana; variant 3 and cv. Picual; variant 3. 1
Natural varianti16Q → R in strain: cv. Acebuche. 1
Natural varianti16Q → T in strain: cv. Bella de Espana; variants 1 and 2, cv. Loaime, cv. Menara; variants 1 and 2, cv. Picholine marocaine and cv. Picual; variants 1 and 2. 1
Natural varianti17V → I in strain: cv. Rowghani; variant 3 and cv. Zard; variant 2. 1
Natural varianti17V → S in strain: cv. Arbequina; variant 2, cv. Bella de Espana; variant 3, cv. Hojiblanca and cv. Picual; variant 3. 1
Natural varianti17V → T in strain: cv. Acebuche. 1
Natural varianti18Y → F in strain: cv. Bella de Espana; variant 1. 1
Natural varianti18Y → H in strain: cv. Menara; variant 2. 1
Natural varianti18Y → S in strain: cv. Bella de Espana; variant 2 and cv. Picual; variant 2. 1
Natural varianti18Y → V in strain: cv. Acebuche. 1
Natural varianti19C → Q in strain: cv. Bella de Espana; variant 2. 1
Natural varianti19C → R in strain: cv. Arbequina; variant 2 and cv. Bella de Espana; variant 1. 1
Natural varianti19C → S in strain: cv. Bella de Espana; variant 3. 1
Natural varianti19C → T in strain: cv. Acebuche. 1
Natural varianti20D → G in strain: cv. Acebuche and cv. Bella de Espana; variant 3. 1
Natural varianti20D → V in strain: cv. Bella de Espana; variant 1. 1
Natural varianti21T → H in strain: cv. Bella de Espana; variant 3. 1
Natural varianti21T → Y in strain: cv. Acebuche. 1
Natural varianti23R → C in strain: cv. Bella de Espana; variant 2. 1
Natural varianti23R → P.1
Natural varianti24A → S in strain: cv. Rowghani; variant 3. In Ole e 1.0105. 1
Natural varianti24A → T in Ole e I.4. 1
Natural varianti25G → R in strain: cv. Bella de Espana; variants 1, 2 and 3 and cv. Rowghani; variants 3 and 4. In Ole e 1.0105, Ole e I.3 and Ole e I.4. 1
Natural varianti28T → A in strain: cv. Zard; variant 2; 50% loss of IgG binding. 1 Publication1
Natural varianti30L → F in Ole e I.4. 1
Natural varianti35P → L in strain: cv. Zard; variant 2. 1
Natural varianti38S → G in strain: cv. Bella de Espana; variants 1, 2 and 3, cv. Hojiblanca and cv. Zard; variant 2. In Ole e I.4. 1
Natural varianti39L → V in strain: cv. Arbequina; variants 1 and 2, cv. Bella de Espana; variants 1, 2 and 3, cv. Hojiblanca, cv. Loaime, cv. Lucio, cv. Menara; variants 1 and 2, cv. Picholine marocaine, cv. Picual; variants 1 and 2, cv. Rowghani; variants 2, 3 and 4 and cv. Zard; variants 1 and 2. In Ole e 1.0102, Ole e 1.0103, Ole e 1.0105, Ole e I.3 and Ole e I.4. 1
Natural varianti44K → R in strain: cv. Rowghani; variants 2, 3 and 4 and cv. Zard; variants 1 and 2. In Ole e 1.0105. 1
Natural varianti45D → E in strain: cv. Zard; variant 1 and cv. Rowghani; variants 2 and 3. In Ole e 1.0105. 1
Natural varianti46K → G in strain: cv. Bella de Espana; variants 1, 2 and 3, cv. Hojiblanca and cv. Rowghani; variant 4. In Ole e I.3 and Ole e I.4. 1
Natural varianti46K → I.1
Natural varianti46K → R in strain: cv. Arbequina; variants 1 and 2. 1
Natural varianti46K → S in strain: cv. Zard; variant 2. 1
Natural varianti47E → K in strain: cv. Rowghani; variant 2 and cv. Zard; variants 1 and 2. 1
Natural varianti48N → K in strain: cv. Zard; variant 2. 1
Natural varianti50D → K in Ole e I.4. 1
Natural varianti50D → N in strain: cv. Bella de Espana; variants 1, 2 and 3, cv. Hojiblanca and cv. Zard; variant 2. 1
Natural varianti50D → S in strain: cv. Rowghani; variant 4. In Ole e I.3. 1
Natural varianti51V → I in strain: cv. Arbequina; variants 1 and 2, cv. Hojiblanca, cv. Loaime, cv. Lucio, cv. Menara; variants 1 and 2, cv. Picholine marocaine, cv. Picual; variants 1 and 2, cv. Rowghani, variants 2, 3 and 4 and cv. Zard; variants 1 and 2. In Ole e 1.0105, Ole e I.3 and Ole e I.4. 1
Natural varianti56V → I in strain: cv. Rowghani; variant 3. In Ole e 1.0102, 1.0103 and 1.0105. 1
Natural varianti58Y → S in strain: cv. Rowghani; variant 4. 1
Natural varianti69V → I in strain: cv. Bella de Espana; variants 1, 2 and 3, cv. Rowghani; variant 4 and cv. Zard; variant 2. In Ole e I.3 and Ole e I.4. 1
Natural varianti75N → D in strain: cv. Rowghani; variant 4. In Ole e I.3. 1
Natural varianti80I → V in strain: cv. Zard; variant 2. 1
Natural varianti81T → N in strain: cv. Zard; variant 2. 1
Natural varianti82L → S in strain: cv. Zard; variant 2. 1
Natural varianti83I → L in strain: cv. Bella de Espana; variants 1, 2 and 3 and cv. Zard; variant 2. In Ole e I.4. 1
Natural varianti86G → S in strain: cv. Bella de Espana; variants 1, 2 and 3, cv. Rowghani; variant 4 and cv. Zard; variant 2. In Ole e I.3 and Ole e I.4. 1
Natural varianti87R → S.1
Natural varianti91N → D in strain: cv. Arbequina; variants 1 and 2, cv. Bella de Espana; variants 1, 2 and 3, cv. Hojiblanca, cv. Loaime, cv. Picual; variants 1 and 2, cv. Rowghani; variants 3 and 4 and cv. Zard; variant 2. In Ole e 1.0105, Ole e I.3 and Ole e I.4. 1
Natural varianti95T → I in strain: cv. Rowghani; variant 3 and cv. Zard; variant 2. In Ole e 1.0105. 1
Natural varianti95T → V in strain: cv. Bella de Espana; variants 1, 2 and 3 and cv. Rowghani; variant 4. In Ole e I.3. 1
Natural varianti99A → V in strain: cv. Acebuche, cv. Arbequina; variants 1 and 2, cv. Bella de Espana; variants 1, 2 and 3, cv. Hojiblanca, cv. Picual; variant 3, cv. Rowghani; variants 1 and 4 and cv. Zard; variant 2. In Ole e I.2, Ole e I.3 and Ole e I.4. 1
Natural varianti100K → R in strain: cv. Zard; variant 2. 1
Natural varianti103L → V in Ole e I.4. 1
Natural varianti104K → R in strain: cv. Zard; variant 2. 1
Natural varianti106K → I in strain: cv. Acebuche, cv. Arbequina; variant 1 and 2, cv. Hojiblanca, cv. Loaime, cv. Lucio, cv. Menara; variants 1 and 2, cv. Picholine marocaine, cv. Picual; variants 1, 2 and 3, cv. Rowghani; variants 1, 2 and 3 and cv. Zard; variant 1. In Ole e 1.0102, Ole e 1.0103, Ole e 1.0105, Ole e I.2 and Ole e I.4. 1 Publication1
Natural varianti106K → L in strain: cv. Zard; variant 2. 1
Natural varianti106K → M in strain: cv. Bella de Espana; variants 1, 2 and 3 and cv. Rowghani; variant 4. In Ole e I.3. 1
Natural varianti108N → S in Ole e 1.0103. 1
Natural varianti111N → D.1
Natural varianti115R → C in strain: cv. Zard; variant 2. 1
Natural varianti117V → I in strain: cv. Bella de Espana; variants 1, 2 and 3, cv. Hojiblanca, cv. Rowghani; variant 2 and cv. Zard; variants 1 and 2. In Ole e I.3 and Ole e I.4. 1
Natural varianti118N → K in strain: cv. Zard; variant 2. 1
Natural varianti121G → R in Ole e 1.0102. 1
Natural varianti123F → Y in strain: cv. Zard; variant 1 and cv. Rowghani; variant 2. In Ole e 1.0102 and Ole e 1.0103. 1
Natural varianti125K → N in strain: cv. Zard; variant 2. 1
Natural varianti126E → K in strain: cv. Zard; variant 2. 1
Natural varianti132A → P in strain: cv. Bella de Espana; variants 1, 2 and 3, cv. Rowghani; variant 4 and cv. Zard; variant 2. In Ole e I.3 and Ole e I.4. 1
Natural varianti135Y → F in strain: cv. Bella de Espana; variants 1, 2 and 3, cv. Rowghani; variant 4 and cv. Zard; variant 2. In Ole e I.3 and Ole e I.4. 1
Natural varianti139G → D in strain: cv. Rowghani; variant 2. 1
Natural varianti144N → D in strain: cv. Bella de Espana; variants 1, 2 and 3, cv. Rowghani; variant 4 and cv. Zard; variant 2. 1
Natural varianti144N → T in strain: cv. Picual; variant 3. 1
Natural varianti145M → HGMSR in strain: cv. Acebuche. 1
Natural varianti145M → L in strain: cv. Zard; variant 2. 1
Natural varianti145M → WNVTI in strain: cv. Picual; variant 3. 1

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
Y12426 mRNA. Translation: CAA73036.1. Different initiation.
Y12427 mRNA. Translation: CAA73037.1. Different initiation.
Y12428 mRNA. Translation: CAA73038.1. Different initiation.
AF500908 mRNA. Translation: AAQ07442.1.
AF515277 mRNA. Translation: AAQ08186.1.
AF515278 mRNA. Translation: AAQ08187.1.
AF515279 mRNA. Translation: AAQ08188.1.
AF515280 mRNA. Translation: AAQ08189.1.
AF515281 mRNA. Translation: AAQ08190.1.
AF532753 mRNA. Translation: AAQ10267.1.
AF532754 mRNA. Translation: AAQ10268.1.
AF532755 mRNA. Translation: AAQ10269.1.
AF532756 mRNA. Translation: AAQ10270.1.
AF532757 mRNA. Translation: AAQ10271.1.
AF532758 mRNA. Translation: AAQ10272.1.
AF532759 mRNA. Translation: AAQ10273.1.
AF532760 mRNA. Translation: AAQ10274.1.
AF532761 mRNA. Translation: AAQ10275.1.
AF532762 mRNA. Translation: AAQ10276.1.
AF532763 mRNA. Translation: AAQ10277.1.
AF532764 mRNA. Translation: AAQ10278.1.
AF532765 mRNA. Translation: AAQ10279.1.
AF532766 mRNA. Translation: AAQ10280.1.
AF532767 mRNA. Translation: AAQ10281.1.
AY137467 mRNA. Translation: AAN18042.1.
AY137468 mRNA. Translation: AAN18043.1.
AY137469 mRNA. Translation: AAN18044.1.
AY159880 Genomic DNA. Translation: AAO22132.1.
AY159881 Genomic DNA. Translation: AAO22133.1.
EF541386 mRNA. Translation: ABP58632.1.
EF541387 mRNA. Translation: ABP58633.1.
EF541388 mRNA. Translation: ABP58634.1.
EF541389 mRNA. Translation: ABP58635.1.
EF541390 mRNA. Translation: ABP58636.1.
EF541391 mRNA. Translation: ABP58637.1.
S75766 mRNA. Translation: AAB32652.2.
PIRiA36153.
A53806.
D53806.
S36872.

Keywords - Coding sequence diversityi

Polymorphism

Cross-referencesi

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
Y12426 mRNA. Translation: CAA73036.1. Different initiation.
Y12427 mRNA. Translation: CAA73037.1. Different initiation.
Y12428 mRNA. Translation: CAA73038.1. Different initiation.
AF500908 mRNA. Translation: AAQ07442.1.
AF515277 mRNA. Translation: AAQ08186.1.
AF515278 mRNA. Translation: AAQ08187.1.
AF515279 mRNA. Translation: AAQ08188.1.
AF515280 mRNA. Translation: AAQ08189.1.
AF515281 mRNA. Translation: AAQ08190.1.
AF532753 mRNA. Translation: AAQ10267.1.
AF532754 mRNA. Translation: AAQ10268.1.
AF532755 mRNA. Translation: AAQ10269.1.
AF532756 mRNA. Translation: AAQ10270.1.
AF532757 mRNA. Translation: AAQ10271.1.
AF532758 mRNA. Translation: AAQ10272.1.
AF532759 mRNA. Translation: AAQ10273.1.
AF532760 mRNA. Translation: AAQ10274.1.
AF532761 mRNA. Translation: AAQ10275.1.
AF532762 mRNA. Translation: AAQ10276.1.
AF532763 mRNA. Translation: AAQ10277.1.
AF532764 mRNA. Translation: AAQ10278.1.
AF532765 mRNA. Translation: AAQ10279.1.
AF532766 mRNA. Translation: AAQ10280.1.
AF532767 mRNA. Translation: AAQ10281.1.
AY137467 mRNA. Translation: AAN18042.1.
AY137468 mRNA. Translation: AAN18043.1.
AY137469 mRNA. Translation: AAN18044.1.
AY159880 Genomic DNA. Translation: AAO22132.1.
AY159881 Genomic DNA. Translation: AAO22133.1.
EF541386 mRNA. Translation: ABP58632.1.
EF541387 mRNA. Translation: ABP58633.1.
EF541388 mRNA. Translation: ABP58634.1.
EF541389 mRNA. Translation: ABP58635.1.
EF541390 mRNA. Translation: ABP58636.1.
EF541391 mRNA. Translation: ABP58637.1.
S75766 mRNA. Translation: AAB32652.2.
PIRiA36153.
A53806.
D53806.
S36872.

3D structure databases

ModBaseiSearch...
MobiDBiSearch...

Protein family/group databases

Allergomei482. Ole e 1.
483. Ole e 1.0101.
487. Ole e 1.0105.
488. Ole e 1.0106.
489. Ole e 1.0107.

PTM databases

UniCarbKBiP19963.

Protocols and materials databases

Structural Biology KnowledgebaseSearch...

Family and domain databases

InterProiIPR006040. Allegen_Ole_e_I_CS.
IPR006041. Pollen_Ole_e1_allergen.
[Graphical view]
PANTHERiPTHR31614:SF2. PTHR31614:SF2. 1 hit.
PROSITEiPS00925. OLEEI. 1 hit.
[Graphical view]
ProtoNetiSearch...

Entry informationi

Entry nameiALL1_OLEEU
AccessioniPrimary (citable) accession number: P19963
Secondary accession number(s): A5A5K8
, A5A5K9, A5A5L0, A5A5L1, A5A5L2, A5A5L3, O24166, O24167, O24168, Q41243, Q5DTB9, Q5DTC0, Q5DTC2, Q5DVQ3, Q5DVQ4, Q5DVQ5, Q5DVQ6, Q5DVQ7, Q5DVQ9, Q5DVR0, Q5DVR4, Q5DVR6, Q5DVS1, Q5DVS3
Entry historyi
Integrated into UniProtKB/Swiss-Prot: February 1, 1991
Last sequence update: October 1, 1993
Last modified: November 30, 2016
This is version 86 of the entry and version 2 of the sequence. [Complete history]
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programPlant Protein Annotation Program

Miscellaneousi

Miscellaneous

Replacement of several other amino acids by Ala has little or no effect on IgG binding.

Keywords - Technical termi

Direct protein sequencing

Documents

  1. Allergens
    Nomenclature of allergens and list of entries
  2. SIMILARITY comments
    Index of protein domains and families

Similar proteinsi

Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:
100%UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry.
90%UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence).
50%UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster.